JP2020514270A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514270A5
JP2020514270A5 JP2019533585A JP2019533585A JP2020514270A5 JP 2020514270 A5 JP2020514270 A5 JP 2020514270A5 JP 2019533585 A JP2019533585 A JP 2019533585A JP 2019533585 A JP2019533585 A JP 2019533585A JP 2020514270 A5 JP2020514270 A5 JP 2020514270A5
Authority
JP
Japan
Prior art keywords
alkyl
group
substituted
aryl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019533585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514270A (ja
JP7471820B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/084346 external-priority patent/WO2018115421A1/en
Publication of JP2020514270A publication Critical patent/JP2020514270A/ja
Publication of JP2020514270A5 publication Critical patent/JP2020514270A5/ja
Priority to JP2022119240A priority Critical patent/JP2022141920A/ja
Application granted granted Critical
Publication of JP7471820B2 publication Critical patent/JP7471820B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019533585A 2016-12-23 2017-12-22 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物 Active JP7471820B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022119240A JP2022141920A (ja) 2016-12-23 2022-07-27 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16206790.4 2016-12-23
EP16206790 2016-12-23
PCT/EP2017/084346 WO2018115421A1 (en) 2016-12-23 2017-12-22 Compounds useful for treating a mannheimia haemolytica or histophilus somni infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022119240A Division JP2022141920A (ja) 2016-12-23 2022-07-27 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物

Publications (3)

Publication Number Publication Date
JP2020514270A JP2020514270A (ja) 2020-05-21
JP2020514270A5 true JP2020514270A5 (cg-RX-API-DMAC10.html) 2021-01-28
JP7471820B2 JP7471820B2 (ja) 2024-04-22

Family

ID=57609790

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019533585A Active JP7471820B2 (ja) 2016-12-23 2017-12-22 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物
JP2022119240A Pending JP2022141920A (ja) 2016-12-23 2022-07-27 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022119240A Pending JP2022141920A (ja) 2016-12-23 2022-07-27 マンヘミア・ヘモリチカ感染症又はヒストフィルス・ソムニ感染症を治療するのに有用な化合物

Country Status (9)

Country Link
US (2) US11034650B2 (cg-RX-API-DMAC10.html)
EP (1) EP3558939A1 (cg-RX-API-DMAC10.html)
JP (2) JP7471820B2 (cg-RX-API-DMAC10.html)
CN (1) CN110072844B (cg-RX-API-DMAC10.html)
AR (1) AR110441A1 (cg-RX-API-DMAC10.html)
AU (2) AU2017380070B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019013016B1 (cg-RX-API-DMAC10.html)
MX (2) MX388647B (cg-RX-API-DMAC10.html)
WO (1) WO2018115421A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017380070B2 (en) 2016-12-23 2022-03-10 Intervet International B.V. Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
BR112019012861A2 (pt) * 2016-12-23 2019-12-10 Intervet Int Bv compostos para o tratamento de doença respiratória bovina ou suína
US11498909B2 (en) * 2018-02-10 2022-11-15 Kbp Biosciences Co., Ltd. Compound acting as antibiotics
AU2019296380B2 (en) 2018-06-25 2024-02-29 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
SG11202102712WA (en) * 2018-09-20 2021-04-29 Forge Therapeutics Inc Antibacterial compounds
CA3233328A1 (en) 2021-09-28 2023-04-06 Min Teng Lpxc inhibitors and uses thereof
CN116183899B (zh) * 2023-04-28 2023-06-30 天津市协和医药科技集团有限公司 一种吖啶酯标记抗体保存液的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51106743A (cg-RX-API-DMAC10.html) * 1975-03-13 1976-09-21 Ueno Seiyaku Oyo Kenkyujo Kk
JPS5257164A (en) * 1975-11-05 1977-05-11 Ueno Seiyaku Oyo Kenkyujo Kk Production of novel nitrofuran derivatives
US6074657A (en) 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
IL164158A0 (en) 2002-03-21 2005-12-18 Pharmacia & Upjohn Co Llc Method of administering an injectable antibiotic to an animal
ES2387803T3 (es) * 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
CA2691987C (en) * 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
NZ603198A (en) * 2010-04-20 2013-10-25 Taisho Pharmaceutical Co Ltd Novel hydroxamic acid derivative
WO2012031298A2 (en) 2010-09-03 2012-03-08 Duke University Ethynylbenzene derivatives
JP6006609B2 (ja) * 2011-10-19 2016-10-12 大正製薬株式会社 新規なヒドロキサム酸誘導体を含有する医薬
EP2847162A1 (en) 2012-05-09 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) * 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
WO2015024010A2 (en) * 2013-08-16 2015-02-19 Duke University Substituted hydroxamic acid compounds
CN105777464B (zh) * 2014-12-26 2020-09-29 中国科学院上海药物研究所 异羟肟酸衍生物及其制备方法和应用
AU2017380070B2 (en) 2016-12-23 2022-03-10 Intervet International B.V. Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
BR112019012861A2 (pt) * 2016-12-23 2019-12-10 Intervet Int Bv compostos para o tratamento de doença respiratória bovina ou suína

Similar Documents

Publication Publication Date Title
JP2020514270A5 (cg-RX-API-DMAC10.html)
JP2016503052A5 (cg-RX-API-DMAC10.html)
JP2017523169A5 (cg-RX-API-DMAC10.html)
JP2015500843A5 (cg-RX-API-DMAC10.html)
JP2018021051A5 (cg-RX-API-DMAC10.html)
JP2016530259A5 (cg-RX-API-DMAC10.html)
JP2010524932A5 (cg-RX-API-DMAC10.html)
JP2018537413A5 (ja) 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
JP2019532928A5 (cg-RX-API-DMAC10.html)
JP2010523522A5 (cg-RX-API-DMAC10.html)
JP2019535723A5 (cg-RX-API-DMAC10.html)
JP2014511892A5 (cg-RX-API-DMAC10.html)
JP2011006480A5 (cg-RX-API-DMAC10.html)
JP2014506907A5 (cg-RX-API-DMAC10.html)
JP2017531038A5 (cg-RX-API-DMAC10.html)
JP2016525102A5 (cg-RX-API-DMAC10.html)
JP2017505785A5 (cg-RX-API-DMAC10.html)
JP2018526399A5 (cg-RX-API-DMAC10.html)
JP2009535307A5 (cg-RX-API-DMAC10.html)
JP2015504081A5 (cg-RX-API-DMAC10.html)
JP2019510034A5 (cg-RX-API-DMAC10.html)
JP2018527301A5 (ja) アジリジン含有dnaアルキル化剤
JP2017517565A5 (cg-RX-API-DMAC10.html)
JP2015536947A5 (cg-RX-API-DMAC10.html)
JP2012512863A5 (cg-RX-API-DMAC10.html)